Kopran share price
You have to be logged in to add this to Watchlist.- ₹122.95(0.00%)March 9, 2026 15:29:20 PM IST
- NSE
- BSE
- Vol : 189.86 K (NSE + BSE)Last 20 day avg : 166.51 K
Kopran is trading 0.00% upper at Rs 122.95 as compared to its last closing price. Kopran has been trading in the price range of 122.95 & 115.75. Kopran has given -18.35% in this year & -7.94% in the last 5 days. Kopran has TTM P/E ratio 44.08 as compared to the sector P/E of 23.53.The company posted a net profit of 9.34 Crores in its last quarter.Listed peers of Kopran include Sun Pharmaceutical Industries (0.48%), Divi's Laboratories (0.40%), Torrent Pharmaceuticals (1.67%).The Mutual Fund holding in Kopran was at 0.94% in 31 Mar 2024. The MF holding has increased from the last quarter. The FII holding in Kopran was at 0.36% in 31 Dec 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Mar 09, 2026, 03:56 PM UTC
- BetaLow volatility0.83Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.29The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldHigher than industry2.44Annual dividends as a percentage of the stock price.
- PEG RatioIndicates undervaluation-2.17The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | Bullish | 1,807.60 | 0.48 | 4,34,647.93 | 36.81 | 5.86 | 0.94 | 0.50 |
| Divi's Laboratories | Neutral | 6,352.85 | 0.40 | 1,70,706.66 | 77.38 | 11.34 | 0.47 | 0.01 |
| Torrent Pharmaceuticals | Bullish | 4,380.00 | 1.67 | 1,47,982.39 | 77.59 | 19.7 | 0.79 | 17.62 |
| Dr Reddy's Laboratories | Neutral | 1,283.50 | -1.56 | 1,07,047.53 | 19.23 | 3.24 | 0.61 | 2.34 |
| Cipla | Bearish | 1,320.00 | -0.13 | 1,06,627.05 | 20.65 | 3.49 | 0.97 | 0.81 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-01-22 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-07-29 | Quarterly Results |
| 2025-05-15 | Audited Results & Final Dividend |
| 2025-02-11 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE082A01010
- BSE Code524280
- NSE CodeKOPRAN
Kopran is trading at 122.95 as on Mon Mar 09 2026 09:59:20. This is 0.00% upper as compared to its previous closing price of 122.95.
The market capitalization of Kopran is 592.71 Cr as on Mon Mar 09 2026 09:59:20.
The 52 wk high for Kopran is 214.65 whereas the 52 wk low is 119.60
Kopran can be analyzed on the following key metrics -
- TTM P/E: 44.08
- Sector P/E: 23.53
- Dividend Yield: 2.44%
- D/E ratio: -
Kopran reported a net profit of 38.55 Cr in 2025.
The Mutual Fund Shareholding was 0.94% at the end of 31 Mar 2024.